1
|
Schussler O, Maroteaux L, Jashari R, Falcoz P, Alifano M, Lecarpentier Y, Launay JM. First quantitative dosages: Strong correlations between non-5-HT2Rs serotonin receptors on normal human heart valves. Front Cardiovasc Med 2022; 9:897657. [DOI: 10.3389/fcvm.2022.897657] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2022] [Accepted: 09/06/2022] [Indexed: 11/13/2022] Open
Abstract
ObjectivesAlthough critical in animal and human development and pathology, a measurement of the quantitative expression of 5-HTR serotonin receptors on animal or human valvular tissues has never been performed.MethodsQuantification of the most frequent 5-HTRs reported as being present in human peripheral tissue was performed using radiolabeled agonists/antagonists. A membrane protein extract from normal human valves (aortic/mitral/tricuspid and some pulmonary) and associated diseased left myocardium, all unusable in clinics, were obtained from the Homograft bank.ResultsWe analyzed 5-HT1AR/5-HT1B/DR/5-HT2AR/5-HT2BR/5-HT 2CR/5-HT4R/5-HT7R from 28 hearts. We confirmed the presence of tissue and measured the quantitative content for respective proteins in femtomol/mg of protein extracts: for 5-HT2AR (35.9+/−0.7), 5-HT2BR (28.8+/−1.3) but also a newly observed and robust expression for 5-HT4R (38+/−4.2). We identified one, 5-HT1ARs (4.9+/−0.3), and the possible expression, but at a very low level, of previously reported 5-HT1B/DRs (1.3+/−0.5) as well as the new 5-HT7Rs (3.5+/0.1) and 5-HT2CRs (1.2+/−0.1). Interestingly, by using univariate analysis, we were able to observe many correlations between the different 5-HTR levels of expression especially between 5-HT1AR/5-HT1B/DR and also between 5-HT4R/5-HT7R, but none were observed between 5-HT2AR and 5-HT2BR. Using multivariate analyses for a specific 5-HTR level of expression, after adjustment for implantation sites and other 5-HTRs, we found that 5-HT1AR was correlated with 5-HT1B/DR;5-HT4R with 5-HT7R and 5-HT1AR;5-HT2BR with 5-HT2AR only. For 5-HT2C, no correlation was observed.Conclusion5-HT2AR/5-HT2BR and 5-HT4R were all observed to have a high and equal level of expression on human valves, but that of 5-HT1AR was more limited. Since these non-5-HT2Rs are coupled with different G-proteins, with specific signaling, theoretically they may control the main 5-HT2R signaling (i.e., PLC/DAG-PKC-ERK/Ras/Src signaling) involved in valvular fibrosis and degeneration.
Collapse
|
2
|
Benítez J, Bluthgen M, Boucher M, Dansin E, Kerjouan M, Bigay-Game L, Pichon E, Thillays F, Falcoz P, Lyubimova S, Oulkhouir Y, Calcagno F, Thiberville L, Clément-Duchêne C, Weestel V, Missy P, Thomas P, Maury J, Molina T, Girard N, Besse B. MA04.01 Multimodality Treatment and Outcome in Stage III Thymic Epithelial Tumors (TETs): A Retrospective Analysis From the French RYTHMIC Network. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
3
|
Matar M, Kessler R, Olland A, Falcoz P, Desprez P, Roche A, Collange O, Chenard MP, Renaud-Picard B, Porzio M. End-Stage Respiratory Failure Secondary to Bronchiolitis Obliterans Syndrome Induced by Toxic Epidermal Necrosis, Also Known as Lyell Syndrome: A Case Report. Transplant Proc 2021; 53:1371-1374. [PMID: 33896544 DOI: 10.1016/j.transproceed.2021.03.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2021] [Accepted: 03/17/2021] [Indexed: 11/17/2022]
Abstract
BACKGROUND Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but serious dermatologic diseases. They can be associated with systemic manifestations such as bronchiolitis obliterans syndrome (BOS). SJS/TEN-induced BOS is associated with a poor prognosis, and no guidelines exist regarding its management. Several case reports have described the association between SJS/TEN and BOS, with few patients undergoing lung transplantation as a last resort therapy. Unfortunately, in the published reports, none of the transplanted patients were observed for a long period of time after the transplantation; therefore, the long-term mortality as well as the risk of recurrence of BOS could not be inferred from these reports. CASE REPORT We present the case of a young patient diagnosed with SJS complicated by BOS and end-stage respiratory failure refractory to corticosteroid therapy. She underwent bilateral lung transplantation with an outstanding outcome at 5-year follow-up. CONCLUSION SJS/TEN-induced BOS might have a favorable evolution and long-term outcomes following lung transplantation. However, prospective studies are needed to confirm this finding.
Collapse
Affiliation(s)
- Maroun Matar
- Strasbourg Lung Transplant Program, University Hospital, Strasbourg, France.
| | - Romain Kessler
- Strasbourg Lung Transplant Program, University Hospital, Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France; Institut National de la Santé et de la Recherche Médicale-Université de Strasbourg, Unité Mixte de Recherche 1260 Regenerative Ranomedecine, Strasbourg, France
| | - Anne Olland
- Strasbourg Lung Transplant Program, University Hospital, Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France; Institut National de la Santé et de la Recherche Médicale-Université de Strasbourg, Unité Mixte de Recherche 1260 Regenerative Ranomedecine, Strasbourg, France
| | - Pierre Falcoz
- Strasbourg Lung Transplant Program, University Hospital, Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France; Institut National de la Santé et de la Recherche Médicale-Université de Strasbourg, Unité Mixte de Recherche 1260 Regenerative Ranomedecine, Strasbourg, France
| | - Philippe Desprez
- Pediatric Intensive Care Unit, University Hospital, Strasbourg, France
| | - Anne Roche
- Surgical Intensive Care Unit, University Hospital, Strasbourg, France
| | - Olivier Collange
- Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France; Surgical Intensive Care Unit, University Hospital, Strasbourg, France
| | | | - Benjamin Renaud-Picard
- Strasbourg Lung Transplant Program, University Hospital, Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France; Institut National de la Santé et de la Recherche Médicale-Université de Strasbourg, Unité Mixte de Recherche 1260 Regenerative Ranomedecine, Strasbourg, France
| | - Michele Porzio
- Strasbourg Lung Transplant Program, University Hospital, Strasbourg, France; Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France
| |
Collapse
|
4
|
Brosseau C, Danger R, Durand M, Durand E, Foureau A, Lacoste P, Tissot A, Roux A, Reynaud-Gaubert M, Kessler R, Mussot S, Dromer C, Brugière O, Mornex JF, Guillemain R, Claustre J, Magnan A, Brouard S, Velly J, Rozé H, Blanchard E, Antoine M, Cappello M, Ruiz M, Sokolow Y, Vanden Eynden F, Van Nooten G, Barvais L, Berré J, Brimioulle S, De Backer D, Créteur J, Engelman E, Huybrechts I, Ickx B, Preiser T, Tuna T, Van Obberghe L, Vancutsem N, Vincent J, De Vuyst P, Etienne I, Féry F, Jacobs F, Knoop C, Vachiéry J, Van den Borne P, Wellemans I, Amand G, Collignon L, Giroux M, Angelescu D, Chavanon O, Hacini R, Martin C, Pirvu A, Porcu P, Albaladejo P, Allègre C, Bataillard A, Bedague D, Briot E, Casez‐Brasseur M, Colas D, Dessertaine G, Francony G, Hebrard A, Marino M, Protar D, Rehm D, Robin S, Rossi‐Blancher M, Augier C, Bedouch P, Boignard A, Bouvaist H, Briault A, Camara B, Chanoine S, Dubuc M, Quétant S, Maurizi J, Pavèse P, Pison C, Saint‐Raymond C, Wion N, Chérion C, Grima R, Jegaden O, Maury J, Tronc F, Flamens C, Paulus S, Philit F, Senechal A, Glérant J, Turquier S, Gamondes D, Chalabresse L, Thivolet‐Bejui F, Barnel C, Dubois C, Tiberghien A, Pimpec‐Barthes F, Bel A, Mordant P, Achouh P, Boussaud V, Méléard D, Bricourt M, Cholley B, Pezella V, Brioude G, D'Journo X, Doddoli C, Thomas P, Trousse D, Dizier S, Leone M, Papazian L, Bregeon F, Coltey B, Dufeu N, Dutau H, Garcia S, Gaubert J, Gomez C, Laroumagne S, Mouton G, Nieves A, Picard C, Rolain J, Sampol E, Secq V, Perigaud C, Roussel J, Senage T, Mugniot A, Danner I, Haloun A, Abbes S, Bry C, Blanc F, Lepoivre T, Botturi‐Cavaillès K, Loy J, Bernard M, Godard E, Royer P, Henrio K, Dartevelle P, Fabre D, Fadel E, Mercier O, Stephan F, Viard P, Cerrina J, Dorfmuller P, Feuillet S, Ghigna M, Hervén P, Le Roy Ladurie F, Le Pavec J, Thomas de Montpreville V, Lamrani L, Castier Y, Mordant P, Cerceau P, Augustin P, Jean‐Baptiste S, Boudinet S, Montravers P, Dauriat G, Jébrak G, Mal H, Marceau A, Métivier A, Thabut G, Lhuillier E, Dupin C, Bunel V, Falcoz P, Massard G, Santelmo N, Ajob G, Collange O, Helms O, Hentz J, Roche A, Bakouboula B, Degot T, Dory A, Hirschi S, Ohlmann‐Caillard S, Kessler L, Schuller A, Bennedif K, Vargas S, Bonnette P, Chapelier A, Puyo P, Sage E, Bresson J, Caille V, Cerf C, Devaquet J, Dumans‐Nizard V, Felten M, Fischler M, Si Larbi A, Leguen M, Ley L, Liu N, Trebbia G, De Miranda S, Douvry B, Gonin F, Grenet D, Hamid A, Neveu H, Parquin F, Picard C, Stern M, Bouillioud F, Cahen P, Colombat M, Dautricourt C, Delahousse M, D'Urso B, Gravisse J, Guth A, Hillaire S, Honderlick P, Lequintrec M, Longchampt E, Mellot F, Scherrer A, Temagoult L, Tricot L, Vasse M, Veyrie C, Zemoura L, Dahan M, Murris M, Benahoua H, Berjaud J, Le Borgne Krams A, Crognier L, Brouchet L, Mathe O, Didier A, Krueger T, Ris H, Gonzalez M, Aubert J, Nicod L, Marsland B, Berutto T, Rochat T, Soccal P, Jolliet P, Koutsokera A, Marcucci C, Manuel O, Bernasconi E, Chollet M, Gronchi F, Courbon C, Hillinger S, Inci I, Kestenholz P, Weder W, Schuepbach R, Zalunardo M, Benden C, Buergi U, Huber L, Isenring B, Schuurmans M, Gaspert A, Holzmann D, Müller N, Schmid C, Vrugt B, Rechsteiner T, Fritz A, Maier D, Deplanche K, Koubi D, Ernst F, Paprotka T, Schmitt M, Wahl B, Boissel J, Olivera‐Botello G, Trocmé C, Toussaint B, Bourgoin‐Voillard S, Séve M, Benmerad M, Siroux V, Slama R, Auffray C, Charron D, Lefaudeux D, Pellet J. Blood CD9 + B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2019; 19:3162-3175. [PMID: 31305014 DOI: 10.1111/ajt.15532] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2018] [Revised: 06/12/2019] [Accepted: 07/07/2019] [Indexed: 01/25/2023]
Abstract
Bronchiolitis obliterans syndrome is the main limitation for long-term survival after lung transplantation. Some specific B cell populations are associated with long-term graft acceptance. We aimed to monitor the B cell profile during early development of bronchiolitis obliterans syndrome after lung transplantation. The B cell longitudinal profile was analyzed in peripheral blood mononuclear cells from patients with bronchiolitis obliterans syndrome and patients who remained stable over 3 years of follow-up. CD24hi CD38hi transitional B cells were increased in stable patients only, and reached a peak 24 months after transplantation, whereas they remained unchanged in patients who developed a bronchiolitis obliterans syndrome. These CD24hi CD38hi transitional B cells specifically secrete IL-10 and express CD9. Thus, patients with a total CD9+ B cell frequency below 6.6% displayed significantly higher incidence of bronchiolitis obliterans syndrome (AUC = 0.836, PPV = 0.75, NPV = 1). These data are the first to associate IL-10-secreting CD24hi CD38hi transitional B cells expressing CD9 with better allograft outcome in lung transplant recipients. CD9-expressing B cells appear as a contributor to a favorable environment essential for the maintenance of long-term stable graft function and as a new predictive biomarker of bronchiolitis obliterans syndrome-free survival.
Collapse
Affiliation(s)
- Carole Brosseau
- Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.,Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.,Institut du thorax, Inserm UMR 1087, CNRS, UMR 6291, Université de Nantes, Nantes, France.,Institut du thorax, CHU de Nantes, Nantes, France
| | - Richard Danger
- Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.,Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France
| | - Maxim Durand
- Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.,Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.,Faculté de Médecine, Université de Nantes, Nantes, France
| | - Eugénie Durand
- Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.,Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France
| | - Aurore Foureau
- Institut du thorax, Inserm UMR 1087, CNRS, UMR 6291, Université de Nantes, Nantes, France.,Institut du thorax, CHU de Nantes, Nantes, France
| | - Philippe Lacoste
- Institut du thorax, Inserm UMR 1087, CNRS, UMR 6291, Université de Nantes, Nantes, France.,Institut du thorax, CHU de Nantes, Nantes, France
| | - Adrien Tissot
- Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.,Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.,Institut du thorax, Inserm UMR 1087, CNRS, UMR 6291, Université de Nantes, Nantes, France.,Institut du thorax, CHU de Nantes, Nantes, France.,Faculté de Médecine, Université de Nantes, Nantes, France
| | - Antoine Roux
- Hôpital Foch, Suresnes, France.,Université Versailles Saint-Quentin-en-Yvelines, UPRES EA220, Versailles, France
| | | | | | - Sacha Mussot
- Centre Chirurgical Marie Lannelongue, Service de Chirurgie Thoracique, Vasculaire et Transplantation Cardiopulmonaire, Le Plessis Robinson, France
| | | | - Olivier Brugière
- Hôpital Bichat, Service de Pneumologie et Transplantation Pulmonaire, Paris, France
| | | | | | - Johanna Claustre
- Clinique Universitaire Pneumologie, Pôle Thorax et Vaisseaux, CHU Grenoble Alpes, Université Grenoble Alpes, Inserm U1055, Grenoble, France
| | - Antoine Magnan
- Institut du thorax, Inserm UMR 1087, CNRS, UMR 6291, Université de Nantes, Nantes, France.,Institut du thorax, CHU de Nantes, Nantes, France
| | - Sophie Brouard
- Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Université de Nantes, Nantes, France.,Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France.,Centre d'Investigation Clinique (CIC) Biothérapie, CHU Nantes, Nantes, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Ardehali A, Van Raemdonck D, Kukreja J, Smith M, Loor G, Rea F, Massard G, De Robertis F, Nagendran J, Moradiellos J, Dhital K, Knosalla C, Bermudez C, Tsui S, Madsen J, Wang I, McCurry K, Deuse T, Thomas P, Tudorache I, Wiegmann B, Schiavon M, Calabrese F, Santelmo N, Olland A, Falcoz P, Varela A, Hertz M, Simon A, Resichenspurner H, Haverich A, Warnecke G. Negative Impact of Primary Graft Dysfunction Grade 3 within the Initial 72 Hours on Short and Long Term Clinical Outcomes in Standard Criteria Double Lung Transplants: Prospective Evidence from the OCS Lung INSPIRE International Trial Results. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.1195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
6
|
Guerrera F, Renaud S, Santelmo N, Evangelista A, Lyberis P, Mazzella A, Olland A, Bora G, Falcoz P, Filosso PL, Ruffini E, Oliaro A, Massard G. F-015MINIMALLY INVASIVE SURGICAL APPROACHES FOR THE TREATMENT OF NON-THYMOMATOUS MYASTHENIA GRAVIS: A COMPARATIVE PROPENSITY-SCORE ADJUSTED MULTICENTRE STUDY. Interact Cardiovasc Thorac Surg 2017. [DOI: 10.1093/icvts/ivx280.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
7
|
Bertolaccini L, Bedetti B, Rocco G, Brunelli A, Papagiannopoulos K, Solli P, Shargall Y, Marinova K, Raveglia F, Kuzdzal J, Massard G, Falcoz P, Ruffini E, Opitz I, Toker A, Batirel H, Scarci M. P-174PLEURAL DISEASES WORKING GROUP OF EUROPEAN SOCIETY OF THORACIC SURGEONS (ESTS): UPDATE OF PROJECT AND ONGOING RESULTS. Interact Cardiovasc Thorac Surg 2017. [DOI: 10.1093/icvts/ivx280.174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
| | - B Bedetti
- Thoracic Surgery, Malteser Hospital, Bonn, Germany
| | - G Rocco
- Division of Thoracic Surgery, Department of Thoracic Surgical And Medical Oncology, Istituto Nazionale Tumouri, Fondazione Pascale, IRCSS, Naples, Italy
| | - A Brunelli
- Department of Thoracic Surgery and Thoracic Endoscopy, St. James’s University Hospital, Leeds, United Kingdom
| | - K Papagiannopoulos
- Department of Thoracic Surgery and Thoracic Endoscopy, St. James’s University Hospital, Leeds, United Kingdom
| | - P Solli
- Thoracic Surgery, AUSL Romagna - Forlì Teaching Hospital, Forlì, Italy
| | - Y Shargall
- Thoracic Surgery, McMaster University, Hamilton, Canada
| | - K Marinova
- Thoracic Surgery, UMHAT – St Marina Varna, Varna, Bulgaria
| | - F Raveglia
- Thoracic Surgery, AO SAN PAOLO, Milan, Italy
| | - J Kuzdzal
- Thoracic Surgery, Jagiellonian University Collegium Medicum, John Paul II Hospital, Krakow, Poland
| | - G Massard
- Department of Thoracic Surgery and Thoracic Endoscopy, University Hospital of Strasbourg, Strasbourg, France
| | - P Falcoz
- Department of Thoracic Surgery and Thoracic Endoscopy, University Hospital of Strasbourg, Strasbourg, France
| | - E Ruffini
- Thoracic Surgery, University of Torino, Torino, Italy
| | - I Opitz
- Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland
| | - A Toker
- Thoracic Surgery, Florence Nightingale Hospital, Istanbul, Turkey
| | - H Batirel
- Thoracic Surgery, Marmara University Faculty of Medicine, Istanbul, Turkey
| | - M Scarci
- Thoracic Surgery, University College London, London, United Kingdom
| | | |
Collapse
|
8
|
Decaluwe H, Petersen RH, Brunelli A, Pompili C, Seguin-Givelet A, Gust L, Aigner C, Falcoz P, Rinieri P, Augustin F, Sokolow Y, Verhagen A, Depypere L, Papagiannopoulos K, Gossot D, D’Journo XB, Guerrera F, Baste J, Schmid T, Stanzi A, Bardet J, Thomas P, Massard G, Moons J, Dooms C, De Leyn P, Hansen HJ. F-014MULTICENTRIC EVALUATION OF THE IMPACT OF CENTRAL TUMOUR LOCATION WHEN COMPARING N1 UPSTAGING BETWEEN VIDEO-ASSISTED THORACOSCOPIC SURGERY AND OPEN SURGERY FOR CLINICAL STAGE I NON-SMALL CELL LUNG CANCER. Interact Cardiovasc Thorac Surg 2017. [DOI: 10.1093/icvts/ivx280.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
9
|
Brunelli A, Rocco G, Salati M, Van Raemdonck D, Decaluwe H, Varela G, Falcoz P. O-008EUROPEAN RISK MODELS FOR MORBIDITY (EUROLUNG1) AND MORTALITY (EUROLUNG2) TO PREDICT OUTCOME FOLLOWING ANATOMIC LUNG RESECTIONS: AN ANALYSIS FROM THE ESTS DATABASE. Interact Cardiovasc Thorac Surg 2016. [DOI: 10.1093/icvts/ivw260.08] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
10
|
Guerrera F, Renaud S, Tabbo F, Voegeli' A, Filosso P, Legrain M, Beau-Faller M, Ruffini E, Falcoz P, Inghirami G, Oliaro A, Massard G. F-036EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS ARE LINKED TO SKIP N2 LYMPH NODE METASTASIS IN RESECTED NON-SMALL CELL LUNG CANCER ADENOCARCINOMAS. Interact Cardiovasc Thorac Surg 2016. [DOI: 10.1093/icvts/ivw260.36] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
11
|
Renaud S, Falcoz P, Schaeffer M, Romain B, Olland A, Reeb J, Voegeli' A, Legrain M, Brigand C, Rohr S, Dominique G, Massard G. F-077PERIOPERATIVE BEVACIZUMAB IMPROVES SURVIVAL IN LUNG METASTASECTOMY OF COLORECTAL CANCER HARBORING KRAS EXON 2 CODON 12 MUTATIONS. Interact Cardiovasc Thorac Surg 2016. [DOI: 10.1093/icvts/ivw260.76] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
12
|
Warnecke G, Van Raemdonck D, Kukreja J, Smith M, Loor G, Rea F, Massard G, De Robertis F, Nagendran J, Moradiellos J, Dhital K, Knosalla C, Bermudez C, Tsui S, Madsen J, Wang I, McCurry K, Deuse T, Thomas P, Sommer W, Weigmann B, Khun C, Tudorache I, Avsar M, Schiavon M, Santelmo N, Olland A, Falcoz P, Varela A, Hertz M, Simon A, Resichenspurner H, Haverich A, Ardehali A. Mid and Long-Term Clinical Results of OCS Lung INSPIRE International Trial. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.042] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
13
|
Warnecke G, Van Raemdonck D, Smith M, Kukreja J, Loor G, Rea F, Massard G, De Robertis F, Nagendran J, Moradiellos J, Dhital K, Knosalla C, Bermudez C, Tsui S, Garcia J, Wang I, McCurry K, Wagner F, Leseche G, Thomas P, Weigmann B, Tudorache I, Kühn C, Avsar M, Sommer W, Schiavon M, Santelmo N, Falcoz P, Olland A, Deuse T, Varela A, Simon A, Madsen J, Hertz M, Reichenspurner H, Haverich A, Ardehali A. The Organ Care System (OCS™) Lung INSPIRE International Trial Results. J Heart Lung Transplant 2015. [DOI: 10.1016/j.healun.2015.01.255] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
14
|
Warnecke G, Haverich A, van Raemdonck D, Massard G, Santelmo N, Falcoz P, Olland A, Leseche G, Mal H, Thomas P, Rea F, Nicotra S, Schiavon M, Marulli G, Knosalla C, Hetzer R, Simon A, Tsui S, Kukreja J, Bermudez C, Moradiellos F, Varela A, Dhital K, Nagendran J, McCurry K, Ardehali A. The INSPIRE International Lung Trial With the Organ Care System Technology (OCSTM) - Interim Report. Transplantation 2014. [DOI: 10.1097/00007890-201407151-00586] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
15
|
Warnecke G, Van Raemdonck D, Massard G, Rea F, Smith M, Kukreja J, De Robertis F, Dhital K, Nagendran J, Moradiellos J, Bermudez C, Tsui S, Leseche G, Knosalla C, McCurry K, Thomas P, Loor G, Garcia J, Wang I, Avsar M, Tudorache I, Kühn C, Wiegmann B, Sommer W, Santelmo N, Falcoz P, Olland A, Schiavon M, Marulli G, Di Gregorio G, Simon A, Hetzer R, Varela A, Madsen J, Hertz M, Haverich A, Ardehali A. The INSPIRE Lung International Trial Evaluating the Impact of Portable Ex-vivo Perfusion Using the Organ Care System (OCS™) Lung Technology on Routine Lung Transplant Outcomes. J Heart Lung Transplant 2014. [DOI: 10.1016/j.healun.2014.01.227] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
16
|
Alifano M, Jablonski C, Kadiri H, Falcoz P, Gompel A, Camilleri-Broet S, Regnard JF. Catamenial and Noncatamenial, Endometriosis-related or Nonendometriosis-related Pneumothorax Referred for Surgery. Am J Respir Crit Care Med 2007; 176:1048-53. [PMID: 17626909 DOI: 10.1164/rccm.200704-587oc] [Citation(s) in RCA: 115] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
RATIONALE Catamenial and endometriosis-related pneumothorax are considered relatively rare entities. Their clinical characteristics and outcome are incompletely known. OBJECTIVES To evaluate the frequencies, clinical characteristics, and outcomes of catamenial and endometriosis-related pneumothoraces occurring in women with no underlying lung disease referred for surgical treatment. METHODS Clinical files of all the women of reproductive age referred to our center during a 6-year period for surgical treatment of spontaneous pneumothorax were retrospectively reviewed. Catamenial pneumothorax (CP) was defined as recurrent pneumothorax occurring between the day before and within 72 hours after the onset of menses. All histologic slides were reviewed to confirm initial diagnoses. MEASUREMENTS AND MAIN RESULTS A total of 114 women underwent video-assisted thoracic surgery; 28 women (24.6%) had CP (right-sided in all but one), and diaphragmatic abnormalities (perforations and/or nodules) were observed in 22 of them. Diaphragmatic abnormalities were seen in 21 of 86 patients with non-CP. Histologic examination found endometriosis, mainly diaphragmatic, in 18 of 28 CPs and 11 of 86 non-CPs. A 6-month antigonadotropic treatment was prescribed postoperatively to women with either CP or endometriosis-related pneumothorax. Mean follow-up was 32.7 (+/-18.5) months. Recurrence rates in CP, non-CP but endometriosis-related, and non-CP non-endometriosis-related pneumothoraces were 32, 27, and 5.3%, respectively. CONCLUSIONS Our experience shows that (1) CP and/or endometriosis-related pneumothoraces account for an important percentage of spontaneous pneumothoraces referred for surgery, (2) diaphragmatic abnormalities seem to play a fundamental role in their pathogenesis, and (3) management is difficult because of the high recurrence rate.
Collapse
Affiliation(s)
- Marco Alifano
- Department of Thoracic Surgery, Hôtel-Dieu Hospital, Paris V University, Paris, France.
| | | | | | | | | | | | | |
Collapse
|
17
|
Falcoz P, Brouchet L, Conti M, Chocron S, Puyraveau M, Mercier M, Etievent J, Dahan M. A surgical predictive risk model of in-hospital mortality for primary resectable lung cancer: Statistical analysis of 8,796 patients from a nationally representative database. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.7677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
7677 Background: The aim of this study was twofold: to identify factors associated with in-hospital mortality among patients operated on for primary resectable lung cancer and to construct a risk model that could be used prospectively to inform decisions and retrospectively to enable comparisons and outcomes. Methods: Data from a nationally representative thoracic surgery database were collected prospectively in 59 hospitals between June 1, 2002 and December 1, 2006. Only adult patients with more than 95% of completed data were selected for the final analysis (n = 8,796 patients). Logistic regression analysis was used to predict the risk of in-hospital mortality. A risk model was developed with a training set of data (50% of patients) and validated on an independent test set (50% of patients). Its fit was assessed by the Hosmer-Lemeshow test (larger p value signifies greater reliability), and predictive accuracy was indicated by the area under the receiver operating characteristic curve (c-index). Results: Of the 8,796 original patients, 255 (2.9%) died during the same hospital admission. Within the data used to develop the model, the factors found to be significantly associated with the occurrence of in-hospital mortality in a multivariate analysis were: age, gender, performance status (World Health Organization) classification, side, class of procedure (lobectomy or wedge resection versus pneumonectomy), tumor histology, TNM stages and presence of co-morbid disease. The model was reliable (Hosmer-Lemeshow test = 8.94; p = 0.35) and accurate: the c-index (95% confidence interval) = 0.83 (0.81 to 0.85) for the training set and 0.82 (0.79 to 0.85) for the test set of data. The correlation between the expected and observed number of deaths was 0.99. Conclusions: The validated multivariate model for risk of in-hospital mortality among adult patients requiring surgery for primary resectable lung cancer described in this report was developed with national data, uses only 8 variables and has good performance characteristics. It would be useful both for calculating the mortality risk of an individual patient and contrasting expected and observed mortality rates for an institution or independent clinician. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- P. Falcoz
- Jean Minjoz Hospital, Besançon, France; Larrey Hospital, Toulouse, France; Calmette Hospital, Lille, France; Saint-Jacques Hospital, Besançon, France; Medical School, Besançon, France
| | - L. Brouchet
- Jean Minjoz Hospital, Besançon, France; Larrey Hospital, Toulouse, France; Calmette Hospital, Lille, France; Saint-Jacques Hospital, Besançon, France; Medical School, Besançon, France
| | - M. Conti
- Jean Minjoz Hospital, Besançon, France; Larrey Hospital, Toulouse, France; Calmette Hospital, Lille, France; Saint-Jacques Hospital, Besançon, France; Medical School, Besançon, France
| | - S. Chocron
- Jean Minjoz Hospital, Besançon, France; Larrey Hospital, Toulouse, France; Calmette Hospital, Lille, France; Saint-Jacques Hospital, Besançon, France; Medical School, Besançon, France
| | - M. Puyraveau
- Jean Minjoz Hospital, Besançon, France; Larrey Hospital, Toulouse, France; Calmette Hospital, Lille, France; Saint-Jacques Hospital, Besançon, France; Medical School, Besançon, France
| | - M. Mercier
- Jean Minjoz Hospital, Besançon, France; Larrey Hospital, Toulouse, France; Calmette Hospital, Lille, France; Saint-Jacques Hospital, Besançon, France; Medical School, Besançon, France
| | - J. Etievent
- Jean Minjoz Hospital, Besançon, France; Larrey Hospital, Toulouse, France; Calmette Hospital, Lille, France; Saint-Jacques Hospital, Besançon, France; Medical School, Besançon, France
| | - M. Dahan
- Jean Minjoz Hospital, Besançon, France; Larrey Hospital, Toulouse, France; Calmette Hospital, Lille, France; Saint-Jacques Hospital, Besançon, France; Medical School, Besançon, France
| |
Collapse
|
18
|
Westeel V, Olaru I, Falcoz P, Ardizzoni A, Choma D, Dubiez A, Jacoulet P, Pugin J, Dalphin J, Depierre A. P-932 False positives of an intensive postoperative follow-up fornon-small cell lung cancer (NSCLC). Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)81425-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
19
|
Pichon H, Chocron S, Alwan K, Toubin G, Kaili D, Falcoz P, Latini L, Clement F, Viel JF, Etievent JP. Crystalloid versus cold blood cardioplegia and cardiac troponin I release. Circulation 1997; 96:316-20. [PMID: 9236451] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
BACKGROUND Cardiac troponin I (CTnI) has been shown to be a marker of myocardial injury. The aim of this study was to compare antegrade crystalloid cardioplegia with antegrade cold blood cardioplegia with warm reperfusion using CTnI release as the criteria for evaluating the adequacy of myocardial protection. METHODS AND RESULTS Seventy patients were randomly assigned to receive crystalloid or blood cardioplegia. CTnI concentrations were measured in serial venous blood samples drawn just before cardiopulmonary bypass and after aortic unclamping at 6, 9, 12, and 24 hours and daily thereafter for 5 days. ANOVA with repeated measures was performed to test the effect of the type of cardioplegia on CTnI release. The total amount of CTnI released was higher in the crystalloid cardioplegia group than in the blood cardioplegia group (11.2 +/- 8.9 versus 7.8 +/- 8.6 micrograms, P < .02). CTnI concentration was significantly higher in the crystalloid group than in the blood group in the samples drawn at hours 9 and 12. Three patients in each group had ECG evidence of perioperative myocardial infarction. Eight patients in the crystalloid group and five patients in the blood group had CTnI evidence of perioperative myocardial infarction. CTnI release was significantly lower in patients requiring no electrical defibrillation after aortic unclamping. CONCLUSIONS Cold blood cardioplegia followed by warm reperfusion is beneficial in an unselected group of patients with a preserved left ventricular function undergoing an elective first coronary artery bypass grafting. CTnI allowed the diagnosis of small perioperative necrotic myocardial areas. The need for electrical defibrillation after aortic unclamping was related to a higher release of CTnI. A further study is necessary to determine whether this technique was beneficial because of cold blood cardioplegia, warm reperfusion, or both.
Collapse
Affiliation(s)
- H Pichon
- Department of Thoracic, Saint-Jacques Hospital, Besancon, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|